Internal Medicine, Endocrinology, Diabetes, & Metabolism · Roanoke, VA
NPI
1285628446
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3501 Colonial Green Circle
Roanoke, VA, 24018
Phone (540) 344-3276
Groups this clinician bills Medicare through
Medicare paid, 2024
$669K
34,607 services
Medicare patients, 2024
1,606
Average age 74
Drug cost, 2024
$6.2M
15,507 prescriptions
Company payments, 2025
$57K
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dewey J Bailey III was code 36415 (venipuncture blood collection), 2,855 times for 1,315 patients. In total Dewey J Bailey III billed 34,607 services in 62 codes, and Medicare paid $669K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 2,855 | 1,315 | $8.64 | $25K |
| 80048 Clinical Chemistry | Office | 2,640 | 1,294 | $8.23 | $22K |
| 84443 Clinical Chemistry | Office | 2,620 | 1,286 | $16.35 | $43K |
| 84439 Clinical Chemistry | Office | 2,589 | 1,272 | $8.77 | $23K |
| 80076 Clinical Chemistry | Office | 2,467 | 1,267 | $7.94 | $20K |
| 99214 Office E&M - Established | Office | 2,140 | 1,109 | $89.93 | $192K |
| 80061 Clinical Chemistry | Office | 1,787 | 886 | $13.06 | $23K |
| 83036 Blood Count | Office | 1,619 | 771 | $9.48 | $15K |
| 82306 Clinical Chemistry | Office | 1,579 | 945 | $28.76 | $45K |
| 85025 Blood Count | Office | 1,313 | 801 | $7.55 | $9,911 |
| 99232 Hospital E&M - Subsequent | Facility | 842 | 172 | $58.58 | $49K |
| 83735 Clinical Chemistry | Office | 824 | 550 | $6.54 | $5,389 |
| 82043 Clinical Chemistry | Office | 611 | 470 | $5.62 | $3,431 |
| 76536 Ultrasound - Nonspecific | Office | 502 | 485 | $74.75 | $38K |
| 99213 Office E&M - Established | Office | 452 | 356 | $60.44 | $27K |
By year: 2022 $611K for 30,963 services; 2023 $723K for 35,291 services; 2024 $669K for 34,607 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,855 | 1,315 | $8.64 | $25K |
| 80048 Clinical Chemistry | 2,640 | 1,294 | $8.23 | $22K |
| 84443 Clinical Chemistry | 2,620 | 1,286 | $16.35 | $43K |
| 84439 Clinical Chemistry | 2,589 | 1,272 | $8.77 | $23K |
| 80076 Clinical Chemistry | 2,467 | 1,267 | $7.94 | $20K |
| 80061 Clinical Chemistry | 1,787 | 886 | $13.06 | $23K |
| 83036 Blood Count | 1,619 | 771 | $9.48 | $15K |
| 82306 Clinical Chemistry | 1,579 | 945 | $28.76 | $45K |
| 85025 Blood Count | 1,313 | 801 | $7.55 | $9,911 |
| 83735 Clinical Chemistry | 824 | 550 | $6.54 | $5,389 |
Medicare prescription drug claims, 2024
In 2024, the drug Dewey J Bailey III prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,746 prescriptions and refills. In total Dewey J Bailey III wrote 15,507 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,746 | 4,743 | 494 | $16K |
| Ozempic Semaglutide | 827 | 1,350 | 179 | $1.3M |
| Metformin Hcl Er Metformin Hcl | 570 | 1,620 | 176 | $4,898 |
| Jardiance Empagliflozin | 569 | 1,065 | 136 | $611K |
| Tresiba Flextouch U-100 Insulin Degludec | 515 | 1,254 | 159 | $428K |
| Synthroid Levothyroxine Sodium | 502 | 1,293 | 139 | $35K |
| Metformin Hcl Generic | 443 | 1,240 | 129 | $2,907 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 313 | 792 | 105 | $65K |
| Rosuvastatin Calcium Generic | 311 | 858 | 92 | $3,049 |
| Atorvastatin Calcium Generic | 292 | 857 | 90 | $2,078 |
| Losartan Potassium Generic | 274 | 784 | 79 | $2,254 |
| Glimepiride Generic | 258 | 701 | 74 | $1,777 |
| Lisinopril Generic | 236 | 626 | 65 | $1,354 |
| Humalog Kwikpen U-100 Insulin Lispro | 236 | 629 | 93 | $99K |
| Farxiga Dapagliflozin Propanediol | 235 | 547 | 62 | $302K |
Brand drugs: 6,883 claims; generic drugs: 7,620 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dewey J Bailey III $57K ($57K in general payments such as food, travel and fees) from 33 companies. The largest payer was Amgen Inc. with $27K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.